Results 31 to 40 of about 38,327 (259)

Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period [PDF]

open access: yes, 2010
Some women are at risk of forming blood clots in a deep vein during pregnancy, after a caesarean birth, or during the first few weeks after childbirth. If part of the clot breaks off and lodges in a blood vessel in the lungs, it can be life-threatening ...
Abou-Nassar   +92 more
core   +1 more source

Advances in the pathophysiology and treatment of heparin-induced thrombocytopenia. [PDF]

open access: yes, 2014
PURPOSE OF REVIEW: To review the recent developments in understanding the pathophysiology of heparin-induced thrombocytopenia (HIT) and in applying this knowledge to the treatment of patients with suspected and proven HIT.
McKenzie, Steven E., Sachais, Bruce S
core   +1 more source

Delayed-onset heparin-induced thrombocytopenia presenting with multiple arteriovenous thromboses: case report

open access: yesJournal of Medical Case Reports, 2007
Background Delayed-onset heparin-induced thrombocytopenia with thrombosis, albeit rare, is a severe side effect of heparin exposure. It can occur within one month after coronary artery bypass grafting (CABG) with manifestation of different thrombotic ...
Omran Abbas   +3 more
doaj   +1 more source

“Spontaneous” Heparin-Induced Thrombocytopenia and Thrombosis After Total Knee Arthroplasty: A Report of 2 Cases

open access: yesArthroplasty Today, 2021
“Spontaneous” heparin-induced thrombocytopenia is a rare and virulent form of heparin-induced thrombocytopenia that occurs in the absence of exposure to any drug of the heparin class of anticoagulants.
Olga M. Olevsky, MD   +1 more
doaj   +1 more source

Thrombosis Resulting from Heparin Therapy [PDF]

open access: yes, 1996
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/90371/1/j.1875-9114.1996.tb02981.x ...
Alaniz, Cesar, Gottschling, Lisa L.
core   +1 more source

Medication Complications in Extracorporeal Membrane Oxygenation. [PDF]

open access: yes, 2017
The need for extracorporeal membrane oxygenation (ECMO) therapy is a marker of disease severity for which multiple medications are required. The therapy causes physiologic changes that impact drug pharmacokinetics.
Aebi   +99 more
core   +2 more sources

Injection Site Erythema in a Patient on Therapeutic Anticoagulation with Low Molecular Weight Heparin after Mechanical Aortic Valve Replacement: A Rare Presentation of Heparin- and Protamine-Induced Thrombocytopenia

open access: yesCase Reports in Immunology, 2020
Previous exposition to heparin and protamine in patients undergoing cardiopulmonary bypass and postoperative therapeutic anticoagulation with LMWH may lead to the development of heparin-induced thrombocytopenia (HIT) and/or protamine-induced ...
Caroline Holaubek   +4 more
doaj   +1 more source

Platelet-Induced Clumping of Plasmodium falciparum–Infected Erythrocytes from Malawian Patients with Cerebral Malaria—Possible Modulation In Vivo by Thrombocytopenia [PDF]

open access: yes, 2008
Platelets may play a role in the pathogenesis of human cerebral malaria (CM), and they have been shown to induce clumping of Plasmodium falciparum–parasitized red blood cells (PRBCs) in vitro.
Barnwell JW   +18 more
core   +1 more source

Acute renal failure due to bilateral renal vein thromboses: A rare complication of heparin-induced thrombocytopenia

open access: yesAnnals of Cardiac Anaesthesia, 2019
Heparin-induced thrombocytopenia type II is a rare but devastating complication of heparin exposure. We review a case of a 66-year-old female who underwent aortic valve surgery requiring venoarterial extracorporeal membranous oxygenation (ECMO) support ...
Allan M Klompas   +3 more
doaj   +1 more source

IgG-class anti-PF4/heparin antibodies and symptomatic DVT in orthopedic surgery patients receiving different anti-thromboembolic prophylaxis therapeutics [PDF]

open access: yes, 2011
Background Heparin-induced thrombocytopenia (HIT) is a thromboembolic complication that can occur with unfractionated heparin (UFH) or low molecular weight heparin (LMWH).
Satoru Motokawa   +8 more
core   +1 more source

Home - About - Disclaimer - Privacy